← Evidence map

ArticleFrontiers in genetics2022

Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs.

Di Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36186449